Glycogen Synthase Kinase 3 Inhibitors in the Next Horizon for Alzheimer's Disease Treatment

Koistinaho, J., Malm, T., & Goldsteins, G. (2011). Glycogen Synthase Kinase-3β: A Mediator of Inflammation in Alzheimer's Disease?. International Journal of Alzheimer＇s Disease, 2011(), 40-48. https://doi.org/10.4061/2011/129753
Rodríguez, S. M., Perry, G., Zhu, X., I.Moreira, P., & Williams, S. (2012). Glycogen Synthase Kinase 3: A Point of Integration in Alzheimer's Disease and a Therapeutic Target?. International Journal of Alzheimer＇s Disease, 2012(), 176-179. https://doi.org/10.1155/2012/276803
Tate, B., McKee, T. D., Loureiro, R. M. B., Dumin, J. A., Xia, W., Pojasek, K., Austin, W. F., Fuller, N. O., Hubbs, J. L., Shen, R., Jonker, J., Ives, J., & Bronk, B. S. (2012). Modulation of Gamma-Secretase for the Treatment of Alzheimer's Disease. International Journal of Alzheimer＇s Disease, 2012(), 95-104. https://doi.org/10.1155/2012/210756
邱世英（2006）。Acetylcholinesterase Inhibition by the Cardiovascular drugs for Alzheimer's disease〔博士論文，中山醫學大學〕。華藝線上圖書館。https://doi.org/10.6834/CSMU.2006.00066
蘇育賢（2012）。The effect of angiotensin converting enzyme inhibitor in the cell model of Alzheimer’s disease〔碩士論文，高雄醫學大學〕。華藝線上圖書館。https://doi.org/10.6832/KMU.2012.00093